Search results
Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial
WSAU Wausau· 10 hours agoBy Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than ...
Tumors shrink for 62% of patients in Merck study
Becker’s Hospital Review· 3 days agoIn a phase 2/3 trial investigating the efficacy of Keytruda with two chemotherapies, tumors shrank among 3 in 5 patients with pleural mesothelioma, Merck said May 29. It often progresses rapidly ...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 15 hours agoWhat will it treat? PCNA is found in all cancers, and AOH1996 has shown promise in 70 cell lines,...
Newswise Expert | Sally York, UT Southwestern Medical Center
Newswise· 22 minutes agoDr. Sally York is a medical oncologist and associate professor who treats patients with lung cancer and pleural mesothelioma at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. York ...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 7 hours agoThe study also linked Trodelvy to a higher number of deaths compared to chemotherapy due to side...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via Yahoo News· 11 hours agoTrodelvy has accelerated U.S. approval for treating advanced urothelial cancer, but Gilead on...
Kate Middleton unlikely to attend Trooping the Colour, feels 'no pressure' to make royal return:...
Fox News via Yahoo News· 2 days agoKate Middleton, the Princess of Wales, is battling an undisclosed form of cancer. The wife of Prince...
Kate wants to be at Trooping the Colour for key reason - but it's not up to her
Daily Express· 4 hours agoKate, who bravely announced her cancer diagnosis in a video message on March 22, continues to...
Isabella Strahan Jokes That Her Brain Is 'Expensive' amid Tumor Treatment
People via Yahoo News· 6 hours agoI’m in a lot of pain. It’s not as bad as last time… my face isn’t as puffy but it literally hurts to...
Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 15 hours agoThe global, open-label, multi-centre, randomised trial involved 711 patients who were previously...